1
Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer
Condition(s):Breast CancerLast Updated:May 14, 2021Completed
Fulvestrant: 400 Clinical Trials, Page 1 of 40
Hide Studies Not Open or Pending
2
Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 Inhibitor
Condition(s):Breast CancerLast Updated:January 6, 2022Not yet recruiting
3
Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC
Condition(s):Advanced Breast Cancer; Metastatic Breast Cancer; Breast Cancer; Breast Carcinoma; Cancer of the Breast; Cancer of Breast; Malignant Tumor of Breast; Breast TumorLast Updated:January 13, 2022Not yet recruiting
4
Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients
Condition(s):Breast CancerLast Updated:December 17, 2021Recruiting
5
GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Condition(s):Locally Advanced or Metastatic Breast CancerLast Updated:September 29, 2021Not yet recruiting
6
A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant
Condition(s):Female Breast Carcinoma; Female Ductal Carcinoma In SituLast Updated:August 18, 2020Terminated
7
Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer
Condition(s):Advanced Breast CancerLast Updated:April 19, 2021Recruiting
8
Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer
Condition(s):Breast CancerLast Updated:November 30, 2020Recruiting
9
Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer.
Condition(s):Postmenopausal Women With ER+ HER2- Primary Breast CancerLast Updated:February 6, 2020Completed
10
Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)
Condition(s):ER-positive Breast Cancer; HER2-negative Breast Cancer; Metastatic CancerLast Updated:January 12, 2022Recruiting